A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...

WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying ...

The U.S. Department of Health and Human Services is planning to drop recommendations for routine COVID-19 vaccines for ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

The EU's General Court annulled on Wednesday a European Commission decision not to disclose text messages Commission ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Lawmakers are investigating whether Pfizer waited to share results of the Covid vaccine in 2020 until after that year’s presidential election, based on new allegations that a former Pfizer ...